Aug. 8, 2024
by Roman Kasianov
News
Cell Microsystems has expanded its contract research lab services to include cell line and custom organoid development, utilizing its proprietary …
July 30, 2024
by Roman Kasianov
News
A study published in Nature Microbiology details a new method for delivering therapeutic proteins to the brain using the parasite …
4D Medicine, a spin-out from the Universities of Birmingham and Warwick, has raised £3.4 million ($4.4 million) in a Series …
July 23, 2024
by Roman Kasianov
News
Proscia, a provider of AI-powered pathology solutions for precision medicine, has announced an update to its Concentriq AP platform. The …
July 22, 2024
by Roman Kasianov
News
A new liquid biopsy approach enables monitoring of disease evolution in patients with metastatic prostate cancer through the analysis of …
July 19, 2024
by Roman Kasianov
News
SkyCell, a technology company specializing in the pharmaceutical supply chain, has partnered with Validaide, a lane risk assessment platform, to …
July 11, 2024
by Andrii Buvailo, PhD
Biopharma insight
Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA …
July 11, 2024
by Roman Kasianov
News
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company, has reached a milestone in the development of a diagnostic tool for …
July 9, 2024
by Roman Kasianov
News
Biostate AI, a startup focused on scalable biodata solutions, has launched two new service products aimed at advancing multiomic data …
July 9, 2024
by Roman Kasianov
News
Researchers at Rockefeller University have developed a new lightweight microscope capable of capturing large-scale brain activity in mice while they …
July 5, 2024
by Roman Kasianov
News
Signet Therapeutics, a biotechnology company specializing in targeted cancer therapy, has received FDA approval for its Investigational New Drug (IND) …
July 3, 2024
by Roman Kasianov
News
Aptamer Group, a developer of novel Optimer® binders for the life sciences industry, has entered into an agreement with AstraZeneca …